Community/Retail

President Trump has nominated Alex M. Azar II to be the next secretary of the United States Department of Health and Human Services.

Does this antihyperglycemic combination medication need to be added to a formulary?

In this clip, Eliot A. Brinton, MD, FAHA, FNLA, president of the Utah Lipid Center, discusses how the EMPA-REG trial is a huge step forward for health care providers being able to treat patients with type 2 diabetes with medications that also reduce cardiovascular risk.

FDA officials took 2 steps today that will extend and facilitate treatment options for patients with schizophrenia and other mental health conditions.

A low sodium-DASH diet combination lowers blood pressure (BP) in adults with hypertension, according to the results of preliminary research at the American Heart Association’s (AHA) Scientific Sessions 2017.

The human papillomavirus (HPV) vaccine can protect against more than cancer-causing types of HPV, according to a recently-published study in The Journal of Infectious Diseases.

"Gut microbiome" is becoming a buzzword in the health care community.

Here are simple ways to get the necessary nutrition and feel energized during a hectic shift.

A growing body of data show that type 2 diabetes is at least in part rooted in inflammation, said Edgar Engleman, MD, a professor of pathology and medicine at Stanford University.

Genome sequencing may be fundamental to eventually offering precision medicine to patients with rheumatoid disease, but it will only reveal part of the patient’s health story.

Officials with the FDA have approved an adjuvanted hepatitis B vaccine, recombinant [Heplisav-B, Dynavax] for the prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older.

Pharmacy Times and Specialty Pharmacy Times recently announced the launch of a new social media campaign to spread awareness about the work pharmacists do to improve their patients' lives.

Learn about the new products and expanded indications approved by the FDA in October 2017.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

How can pharmacists handle the common dilemma of customers who show up after the store has shut its doors for the day?

Why wait until January to take positive steps to improve your life? Dig into at least one of these volumes now to get a boost.

The United States Preventive Services Task Force (USPSTF) has issued an updated draft recommendation statement on osteoporosis screening to prevent fractures.

A newly-updated clinical guideline provides recommendations on the best types and amounts of medications to treat seasonal allergic rhinitis (SAR).

With the odds of getting into a program just a little better than 1 in 2, how can students make sure that they are successful?

Contrary to what many believe, focusing on the negative can provide a path to success.

Ears are self-cleaning, but there are times when a blockage needs to be cleared. Here is a safe and effective at-home method to try.

State and local marijuana laws continue to evolve toward legalization much faster than the scientific community can collect the data to help society weigh the health, safety, and ethical ramifications of these new laws.

Providing web-based vaccine information with social media components during pregnancy can allay concerns about childhood vaccination.

Canagliflozin (Invokana, Janssen) improved renal outcomes and demonstrated potential renal protective effects, according to additional analyses from the CANVAS clinical trial presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.

The findings demonstrated that female gender, older age, and Caucasian race were the most likely predictors of opioid use in patients with JFMS.

Patients with rheumatoid arthritis (RA) who took biologics or triple therapy had a longer fail time than patients who took methotrexate oral monotherapy, suggesting that these treatments may be a good follow-up to failed first-line methotrexate treatment.